|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
3
|
Zenith Epigenetics
|
Jul 29, 2019 03:49PM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
3
|
Zenith Epigenetics
|
Jul 26, 2019 03:07PM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
3
|
Zenith Epigenetics
|
Jul 26, 2019 02:59PM
|
|
Re: ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?
|
3
|
Resverlogix Corp.
|
Jul 06, 2019 01:53PM
|
|
Prostate Cancer News Today Article
|
4
|
Zenith Epigenetics
|
Jul 03, 2019 01:07PM
|
|
Re: Zenith funding???
|
5
|
Zenith Epigenetics
|
Jun 25, 2019 02:54PM
|
|
Re: Fair warning to everyone here....
|
5
|
Resverlogix Corp.
|
Jun 25, 2019 08:33AM
|
|
Re: Zenith funding???
|
3
|
Zenith Epigenetics
|
Jun 24, 2019 04:43PM
|
|
Re: Zenith funding???
|
2
|
Zenith Epigenetics
|
Jun 24, 2019 01:48PM
|
|
Re: Array and Zenith
|
4
|
Zenith Epigenetics
|
Jun 22, 2019 12:26PM
|
|
Re: Why are you invested in RVX
|
4
|
Resverlogix Corp.
|
Jun 19, 2019 12:46PM
|
|
Re: Wouldn’t the timing be great?
|
4
|
Zenith Epigenetics
|
Jun 18, 2019 12:36PM
|
|
Re: Zenith funding???
|
2
|
Zenith Epigenetics
|
Jun 18, 2019 12:19PM
|
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
2
|
Resverlogix Corp.
|
Jun 18, 2019 11:58AM
|
|
Re: Zenith funding???
|
3
|
Zenith Epigenetics
|
Jun 17, 2019 01:57PM
|
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
2
|
Resverlogix Corp.
|
Jun 17, 2019 01:33PM
|
|
Re: My estimate for Top Line Data Announcement...is a shocker!
|
4
|
Resverlogix Corp.
|
Jun 08, 2019 12:56PM
|
|
Re: My estimate for Top Line Data Announcement...is a shocker!
|
4
|
Resverlogix Corp.
|
Jun 07, 2019 02:26PM
|
|
Re: kelsee
|
1
|
Resverlogix Corp.
|
May 22, 2019 04:48PM
|
|
Sell Zenith Shares
|
1
|
Zenith Epigenetics
|
May 09, 2019 02:55PM
|
